1. Home
  2. HRMY vs USA Comparison

HRMY vs USA Comparison

Compare HRMY & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • USA
  • Stock Information
  • Founded
  • HRMY 2017
  • USA 1986
  • Country
  • HRMY United States
  • USA United States
  • Employees
  • HRMY N/A
  • USA N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • USA Finance Companies
  • Sector
  • HRMY Health Care
  • USA Finance
  • Exchange
  • HRMY Nasdaq
  • USA Nasdaq
  • Market Cap
  • HRMY 1.9B
  • USA 1.9B
  • IPO Year
  • HRMY 2020
  • USA N/A
  • Fundamental
  • Price
  • HRMY $26.10
  • USA $6.28
  • Analyst Decision
  • HRMY Strong Buy
  • USA
  • Analyst Count
  • HRMY 10
  • USA 0
  • Target Price
  • HRMY $50.80
  • USA N/A
  • AVG Volume (30 Days)
  • HRMY 1.0M
  • USA 880.5K
  • Earning Date
  • HRMY 10-28-2025
  • USA 01-01-0001
  • Dividend Yield
  • HRMY N/A
  • USA 9.66%
  • EPS Growth
  • HRMY 58.41
  • USA N/A
  • EPS
  • HRMY 3.10
  • USA N/A
  • Revenue
  • HRMY $772,527,000.00
  • USA N/A
  • Revenue This Year
  • HRMY $19.94
  • USA N/A
  • Revenue Next Year
  • HRMY $16.65
  • USA N/A
  • P/E Ratio
  • HRMY $8.37
  • USA N/A
  • Revenue Growth
  • HRMY 17.74
  • USA N/A
  • 52 Week Low
  • HRMY $25.58
  • USA $5.62
  • 52 Week High
  • HRMY $41.61
  • USA $7.09
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 30.89
  • USA 40.48
  • Support Level
  • HRMY $25.95
  • USA $6.17
  • Resistance Level
  • HRMY $26.97
  • USA $6.38
  • Average True Range (ATR)
  • HRMY 0.79
  • USA 0.09
  • MACD
  • HRMY 0.19
  • USA -0.01
  • Stochastic Oscillator
  • HRMY 26.11
  • USA 35.86

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

Share on Social Networks: